Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin.
Zaragoza-Huesca D, Rodenas MC, Peñas-Martínez J, Pardo-Sánchez I, Peña-García J, Espín S, Ricote G, Nieto A, García-Molina F, Vicente V, Lozano ML, Carmona-Bayonas A, Mulero V, Pérez-Sánchez H, Martínez-Martínez I. Zaragoza-Huesca D, et al. Among authors: perez sanchez h. Biomed Pharmacother. 2023 Dec;168:115814. doi: 10.1016/j.biopha.2023.115814. Epub 2023 Oct 31. Biomed Pharmacother. 2023. PMID: 37918256 Free article.
Curcumin-Based Inhibitors of Thrombosis and Cancer Metastasis Promoting Factor CLEC 2 from Traditional Medicinal Species Curcuma longa.
Chandra Manivannan A, Bargueňo MC, Devaraju V, Sen P, Pérez-Sánchez H, Mohammed Ghilan AK, Farasani A, Oyouni AAA, Aljohani SAS, Alzahrani OR, Altayar MA, Sahal Aeban RH, Velmurugan P, Mohanavel V, Sathiamoorthi T, Krishnaraj R. Chandra Manivannan A, et al. Evid Based Complement Alternat Med. 2022 Jan 17;2022:9344838. doi: 10.1155/2022/9344838. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35082906 Free PMC article.
Characterization, in Vivo Evaluation, and Molecular Modeling of Different Propofol-Cyclodextrin Complexes To Assess Their Drug Delivery Potential at the Blood-Brain Barrier Level.
Shityakov S, Salmas RE, Durdagi S, Salvador E, Pápai K, Yáñez-Gascón MJ, Pérez-Sánchez H, Puskás I, Roewer N, Förster C, Broscheit JA. Shityakov S, et al. J Chem Inf Model. 2016 Oct 24;56(10):1914-1922. doi: 10.1021/acs.jcim.6b00215. Epub 2016 Sep 23. J Chem Inf Model. 2016. PMID: 27589557
133 results